Nuo Therapeutics, Inc. (AURX) › Capital ExpendituresNuo Therapeutics, Inc. (AURX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $774.6K2011: $66.4K2013: $750.7K2014: $483.0K2015: $698.2K2019: $02020: $02021: $02022: $60.0K2023: $7.2K2024: $155.0K2025: $274.8K$274.8K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$274.8K+77.3%2024$155.0K+2039.2%2023$7.2K-87.9%2022$60.0K—2021$0—2020$0—2019$0—2015$698.2K+44.6%2014$483.0K-35.7%2013$750.7K—2011$66.4K-91.4%2010$774.6K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share